Sesen Bio and Qilu Pharmaceutical Announce Approval of IND Application in China for Vicineumâ„¢

Go back to Sesen Bio and Qilu Pharmaceutical Announce Approval of IND Application in China for Vicineumâ„¢
(NASDAQ: SESN) Delayed: 2.33 +0.05 (2.19%)
Previous Close $2.28    52 Week High
Open $2.30    52 Week Low
Day High $2.40    P/E N/A 
Day Low $2.29    EPS
Volume 3,158,124